Cargando…
Inhibition of RFX6 Suppresses the Invasive Ability of Tumor Cells Through the Notch Pathway and Affects Tumor Immunity in Hepatocellular Carcinoma
BACKGROUND: The DNA-binding protein RFX6 was overexpressed in hepatocellular carcinoma, and its expression level was correlated with the prognosis and immune cell infiltration in liver hepatocellular carcinoma. However, the mechanism of the abnormal expression and the biological effects of RFX6 in l...
Autores principales: | Song, Mu, Kuerban, Mulati, Zhao, Lu, Peng, Xiaolin, Xu, Youqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721116/ https://www.ncbi.nlm.nih.gov/pubmed/34988028 http://dx.doi.org/10.3389/fonc.2021.801222 |
Ejemplares similares
-
Notching on Cancer’s Door: Notch Signaling in Brain Tumors
por: Teodorczyk, Marcin, et al.
Publicado: (2015) -
Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes
por: Schwab, Katjana, et al.
Publicado: (2023) -
Notch Signaling in Neuroendocrine Tumors
por: Crabtree, Judy S., et al.
Publicado: (2016) -
Androgen Receptors Act as a Tumor Suppressor Gene to Suppress Hepatocellular Carcinoma Cells Progression via miR-122-5p/RABL6 Signaling
por: Tang, Neng, et al.
Publicado: (2021) -
QRFXFreeze: Queryable Compressor for RFX
por: Senthilkumar, Radha, et al.
Publicado: (2015)